FI67559C - Foerfarande foer framstaellning av terapeutiskt anvaendbar 3-0-(beta-d-glukuronopyranosyl)-soijasapogenol b - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbar 3-0-(beta-d-glukuronopyranosyl)-soijasapogenol b Download PDF

Info

Publication number
FI67559C
FI67559C FI791011A FI791011A FI67559C FI 67559 C FI67559 C FI 67559C FI 791011 A FI791011 A FI 791011A FI 791011 A FI791011 A FI 791011A FI 67559 C FI67559 C FI 67559C
Authority
FI
Finland
Prior art keywords
formula
compound
glucuronopyranosyl
soy
iii
Prior art date
Application number
FI791011A
Other languages
English (en)
Finnish (fi)
Other versions
FI791011A (fi
FI67559B (fi
Inventor
Masano Shinora
Yoshimasa Nakano
Hirotsugu Kaise
Taketoshi Izawa
Wasei Miyazaki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of FI791011A publication Critical patent/FI791011A/fi
Application granted granted Critical
Publication of FI67559B publication Critical patent/FI67559B/fi
Publication of FI67559C publication Critical patent/FI67559C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
FI791011A 1978-03-31 1979-03-27 Foerfarande foer framstaellning av terapeutiskt anvaendbar 3-0-(beta-d-glukuronopyranosyl)-soijasapogenol b FI67559C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3853678 1978-03-31
JP53038536A JPS5822120B2 (ja) 1978-03-31 1978-03-31 ３−０−（β−Ｄ−グルクロノピラノシル）−ソ−ヤサポゲノ−ルＢ

Publications (3)

Publication Number Publication Date
FI791011A FI791011A (fi) 1979-10-01
FI67559B FI67559B (fi) 1984-12-31
FI67559C true FI67559C (fi) 1985-04-10

Family

ID=12527996

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791011A FI67559C (fi) 1978-03-31 1979-03-27 Foerfarande foer framstaellning av terapeutiskt anvaendbar 3-0-(beta-d-glukuronopyranosyl)-soijasapogenol b

Country Status (23)

Country Link
US (1) US4217345A (pt)
JP (1) JPS5822120B2 (pt)
AR (1) AR227624A1 (pt)
AT (1) AT369426B (pt)
AU (1) AU527201B2 (pt)
BE (2) BE875106A (pt)
CA (1) CA1128498A (pt)
CH (1) CH640868A5 (pt)
DE (1) DE2911353A1 (pt)
DK (1) DK162102C (pt)
ES (2) ES478874A1 (pt)
FI (1) FI67559C (pt)
FR (1) FR2421179A1 (pt)
GB (1) GB2020290B (pt)
IT (1) IT1126812B (pt)
MX (1) MX6305E (pt)
NL (1) NL7902449A (pt)
NO (1) NO154584C (pt)
PH (1) PH16275A (pt)
PT (1) PT69423A (pt)
SE (1) SE434269B (pt)
SU (2) SU1074408A3 (pt)
ZA (1) ZA791061B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
JPH0621072B2 (ja) * 1986-11-12 1994-03-23 呉羽化学工業株式会社 エストラジオ−ル誘導体よりなる免疫調節剤
US6784159B2 (en) * 2000-09-29 2004-08-31 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture Triterpene saponins from soybeans for treating kidney disease
EP1422509A1 (en) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysing Reagent and Method of Lysing Red Blood Cells for Hematology
CA2539061A1 (en) * 2003-09-22 2005-03-31 Biovation Gmbh & Co. Kg Use of an antagonist of il-6 for treating il-6-mediated diseases
US20070141121A1 (en) * 2005-12-20 2007-06-21 Calton Gary J Method of treating kidney disease
EP2727586A4 (en) * 2011-06-28 2014-11-26 J Oil Mills Inc SOYASAPOGENOL COMPOSITION
CN106589043B (zh) * 2015-10-16 2019-02-26 复旦大学 芳基取代丙烯酰基三萜类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377001A (en) * 1976-11-16 1978-07-08 Otsuka Pharmaceut Co Ltd New material and its preparation
JPS5399314A (en) * 1977-02-04 1978-08-30 Otsuka Pharmaceut Co Ltd Therapeutic agent for nephritis
AU528415B2 (en) * 1978-03-31 1983-04-28 Otsuka Pharmaceutical Co., Ltd. Anticomplementary agents

Also Published As

Publication number Publication date
ZA791061B (en) 1980-03-26
ES487982A0 (es) 1981-01-16
IT1126812B (it) 1986-05-21
ATA236079A (de) 1982-05-15
GB2020290B (en) 1982-10-27
FR2421179B1 (pt) 1983-03-18
IT7948551A0 (it) 1979-03-30
DK162102B (da) 1991-09-16
NL7902449A (nl) 1979-10-02
SE7902866L (sv) 1979-10-16
ES8102148A1 (es) 1981-01-16
JPS54130551A (en) 1979-10-09
SU1190989A3 (ru) 1985-11-07
DK126679A (da) 1979-10-01
NO790994L (no) 1979-10-02
AR227624A1 (es) 1982-11-30
CH640868A5 (de) 1984-01-31
BE875105A (fr) 1979-09-26
AT369426B (de) 1982-12-27
BE875106A (fr) 1979-09-26
DK162102C (da) 1992-02-24
SU1074408A3 (ru) 1984-02-15
NO154584B (no) 1986-07-28
AU4499579A (en) 1979-10-04
NO154584C (no) 1986-11-05
FR2421179A1 (fr) 1979-10-26
CA1128498A (en) 1982-07-27
DE2911353A1 (de) 1979-10-11
DE2911353C2 (pt) 1987-10-29
GB2020290A (en) 1979-11-14
PT69423A (en) 1979-04-01
FI791011A (fi) 1979-10-01
PH16275A (en) 1983-08-26
AU527201B2 (en) 1983-02-24
ES478874A1 (es) 1980-10-01
MX6305E (es) 1985-03-29
FI67559B (fi) 1984-12-31
JPS5822120B2 (ja) 1983-05-06
US4217345A (en) 1980-08-12
SE434269B (sv) 1984-07-16

Similar Documents

Publication Publication Date Title
JP3286321B2 (ja) 新規なアミノステロール抗生物質
FI84074B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara gangliosidderivat.
Chambers et al. Isolation of glycine betaine and proline betaine from human urine. Assessment of their role as osmoprotective agents for bacteria and the kidney.
DE69032206T2 (de) Lipid-a-derivate sowie deren verwendungen
US3929994A (en) Anti-inflammatory glycoprotein compositions and method of use
FI67559C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbar 3-0-(beta-d-glukuronopyranosyl)-soijasapogenol b
US4456596A (en) Wound healing glycoside compositions
JPH01157995A (ja) 鎮痛−抗炎症活性を有するガングリオシドの内部エステル
Morris et al. Comparative studies on immunologically and non-immunologically produced slow-reacting substances from man, guinea-pig and rat.
EP0038511A2 (en) Wound healing compositions
CA1122899A (en) Anticomplementary agents
EP0182851B1 (en) Primycin components and process for the separation of the antibiotic complex
Hochstein Alkaloids of Rauwolfia sellowii
US4382887A (en) Novel glycopeptide and methods of isolating and using the same
CA1339111C (en) Antiviral agent
RU2028381C1 (ru) Способ получения сульфатированного производного галактана
Watanabe et al. Purification and some physicochemical properties of slow-reacting substance of anaphylaxis (SRS-A) from sensitized guinea pig lung
US4393055A (en) Hydroxyalkyl ether derivatives of rutin poly(H-)sulfate and method of use
US4359461A (en) Mono-, di- and tri-adamantylcarbonyl- digalactopyranosyl- glucopyranosyl- fructofuranose sulfate salts
US4440758A (en) Poly-cation salts of bis(or tris)[4-O-monohexose-oxy]-arylene sulfate derivatives
PT88439B (pt) Processo para a preparacao de novos polissacaridos soluveis em agua
US20240287214A1 (en) Chlorella mannogalactan or sulfated chlorella mannogalactan compound and application of sulfated chlorella mannogalactan compound
KR830000619B1 (ko) 3-0(β-D-글루쿠로노피라노실)-소야사포게놀 B의 제조방법
US4168316A (en) Immunosuppressive-1-(thiocarbamoyl)-2-imidazolidinone
COFFEY STUDIES ON THE METABOLISM OF L-FUCOSE.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: OTSUKA PHARMACEUTICAL CO., LTD.